Funder
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference16 articles.
1. Auffenberg GB, Gonzalez CM, Wolf JS Jr, Clemens JQ, Meeks W, McVary KT. An observational analysis of provider adherence to AUA guidelines on the management of benign prostatic hyperplasia. J Urol. 2014;192:1483–8.
2. Wei JT, Miner MM, Steers WD, Rosen RC, Seftel AD, Pasta DJ, et al. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. J Urol. 2011;186:971–6.
3. Welliver C, Feinstein L, Ward JB, Fwu CW, Kirkali Z, Bavendam T, et al. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004-2013: The Urologic Diseases in America Project. J Urol. 2019. https://doi.org/10.1097/JU0000000000000499.
4. United States Renal Data System. USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018. p. 2018.
5. A. U. A. Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003;170:530–47.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献